Summary
The FDA has approved a new preventative treatment for HIV called Lenacapavir, which requires only two injections a year and provides almost complete protection against the virus. However, budget cuts to health programs may affect how quickly the treatment becomes available.
Key Facts
- The FDA has approved a new treatment for preventing HIV called Lenacapavir.
- Lenacapavir offers nearly 100% protection from HIV.
- People need only two injections of Lenacapavir each year.
- There are concerns that cuts to health programs might slow the treatment's distribution.
- Mitchell Warren from the AIDS Vaccine Advocacy Coalition discussed the treatment's impact.
